Home
Foresite Capital Management IV, 10% Owner: Eikon Therapeutics EIKN Buy · Filed 02/06
Trade details
- Type
- Insider buy
- Amount
- $999,990
- Shares · price
- 55,555 sh · $18.00 a share
- Held after
- 1,318,983 sh
- Trade date
- 26/02/04
- Filed
- 26/02/06
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 23 insiders
- Holding change
- +4.4%
Eikon Therapeutics trades, last 26 weeks
What else happened in Eikon Therapeutics around then
Filed or reported within 30 days of the trade day · 01/05~03/06Foresite Capital Management IV's recent trades
- Foresite Capital Management IV
BuyKinnate Biopharma
BuyKinnate Biopharma
KNTE
$4.3M
1,550,956 sh
$4.3M
Filed 23/05/10
Traded 23/05/08
- Foresite Capital Management IV
BuyKinnate Biopharma
BuyKinnate Biopharma
KNTE
$641.3K
229,044 sh
$641.3K
Filed 23/05/10
Traded 23/05/08